EAN 2020 | Therapeutic options in multiple sclerosis

Name: Therapeutic options in multiple sclerosis
Uploaded: 2020-05-24T00:00:00Z
Duration: 4 min 8 s
Description: Celia Oreja-Guevara, MD, PhD, University Hospital San Carlos, Madrid, Spain, outlines the current therapeutic options in multiple sclerosis and discusses the unmet needs in the field. This interview was recorded during an online conference call with The Video Journal of Neurology (VJNeurology).

Celia Oreja-Guevara • 24 May 2020

EAN 2020

Multiple Sclerosis and Related Disorders Antibodies Interferon-beta Ocrelizumab

Celia Oreja-Guevara, MD, PhD, University Hospital San Carlos, Madrid, Spain, outlines the current therapeutic options in multiple sclerosis and discusses the unmet needs in the field. This interview was recorded during an online conference call with The Video Journal of Neurology (VJNeurology).